Clinical trial
Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With…
NCT00496197 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00496197 |
|---|---|
| Title | Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis |
| Official title | Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug |
| Interventions | Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) |
| Enrollment | 282 |
| Start date | Jul 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jul 4, 2007 |
| Last update posted | Oct 3, 2011 |
| Countries | South Korea, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: